glp-1-rezeptoragonisten Was sind GLP-1 Rezeptoragonisten und wie wirken sie? – Diabetes-Anker S3-Leitlinie empfiehlt GLP-1-Rezeptoragonisten bei pädiatrischer

The FDA labeling for most GLP-1 receptor agonists simply says "any time of day." But that does not mean timing is irrelevant

M.PedrazaA

These results do not apply to compounded versions of GLP-1 drugs, which are not FDA-approved and have not been evaluated for safety, effectiveness, or quality

SURPASS-CVOT will not compare tirzepatide to placebo as commonly done

Its high sulforaphane content sets it apart

LPS mainly acts through the activation of toll-like receptor 4 (TLR4), a membrane bound receptor that serves as a convergence point for both infectious and non-infectious stimuli, triggering a proinflammatory response5